PURA - Puration Announces Cannabis Cultivation And Cannabis Infused Beverage Business Updates
April 12 2018 - 9:42AM
InvestorsHub NewsWire
Dallas, TX -- April 12,
2018 -- Puration, Inc. (USOTC:
PURA), today announced two separately scheduled shareholder
updates to review the latest milestone achievements of the
company’s cannabis cultivation business and cannabis infused
beverage business. On Tuesday, April 17th, next
week, the company will present an update on the company’s First
Choice Nursery operations anticipated to report its first sales in
the upcoming Q1 financial report. The update will include the
latest developments on the acquisition of a cannabis cultivation
business in Canada that could potentially change Puration’s
trajectory. On Thursday, April 19th, next week,
the company will present an update on the company’s ongoing
cannabis infused beverage sales led today with its EVERx CBD
Infused Sports Drink. The company has recently signed new
distribution contracts, details of which will be included in next
week’s presentation, in addition to details on the company plans to
soon announce a new cannabis infused beverage line for the legal
recreational marijuana markets.
For more information on EVERx,
visit http://www.drinkeverx.com.
For more information on Puration,
visit http://www.aciconglomerated.com.
Disclaimer/Safe
Harbor:
This news release contains
forward-looking statements within the meaning of the Securities
Litigation Reform Act. The statements reflect the Company's current
views with respect to future events that involve risks and
uncertainties. Among others, these risks include the expectation
that any of the companies mentioned herein will achieve significant
sales, the failure to meet schedule or performance requirements of
the companies' contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure, or prevent any disease.
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
+1-800-861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Apr 2023 to Apr 2024